ITA in the News

Treating Prisoners With Hepatitis C May Be Worth The Hefty Price

Published by NPR 11/23/2015

by Alison Kodjak

Doctors, patients and insurers have been struggling with how to determine who should be treated for hepatitis C now that effective but wildly expensive drugs can all but cure the disease. Treating prison inmates is a good investment that would save money in the long run, a study finds.


New Treatments Not Enough to Eliminate Hepatitis C

Laird Harrison

November 17, 2015

SAN FRANCISCO — Despite powerful new medications, the lack of screening and treatment capacity will make it
difficult to eliminate the hepatitis C virus in the United States, according to projections presented here at the Liver Meeting 2015.

Current trends show that even after 2020, more than 500,000 people will be unaware that they are infected with
hepatitis C, said Jagpreet Chhatwal, PhD, from the Massachusetts General Hospital and Harvard Medical School in Boston. 


Page 1 of 21

<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>